MRI

GE Healthcare Announces U.S. FDA Approval of Macrocyclic MRI Contrast Agent Clariscan™ (Gadoterate Meglumine) in Pre-Filled Syringes

U.S. FDA approves pre-filled syringe packaging for the macrocyclic gadolinium-based contrast agent, Clariscan™ (gadoterate meglumine). Clariscan has been approved in more than 70 countries globally, with more than seven million patient doses shipped, and now offers a wider range of packaging solutions. Clariscan in pre-filled syringes offers potential advantages for workflow safety and efficiency. GE […]

Monteris Medical Announces Favorable 12-Month Outcomes for Patients Receiving Minimally Invasive Laser Ablation for Brain Tumors

PLYMOUTH, Minn. –  April 23, 2020 – Monteris Medical, a pioneer and leader in the market for minimally invasive, image-guided laser ablation systems, announced today that results from a multicenter clinical study of its NeuroBlate® System have been published in the peer-reviewed journalNeurosurgery. Authored by physicians at 14 leading academic medical centers, the prospective study involving 223 brain […]

Monteris Medical Founders to Receive Pioneer in Technology Award

The award recognizes Monteris Medical founders Mark G. Torchia and Richard Tyc for the development of the minimally invasive NeuroBlate® System PLYMOUTH, Minn. – March 2, 2020 – Monteris Medical, the leader in image-guided laser ablation systems for the brain, announced today that its founders, Mark G. Torchia and Richard Tyc, are the 2020 recipients […]